168 related articles for article (PubMed ID: 23076651)
1. The experimental renal cell carcinoma model in the chick embryo.
Fergelot P; Bernhard JC; Soulet F; Kilarski WW; Léon C; Courtois N; Deminière C; Herbert JM; Antczak P; Falciani F; Rioux-Leclercq N; Patard JJ; Ferrière JM; Ravaud A; Hagedorn M; Bikfalvi A
Angiogenesis; 2013 Jan; 16(1):181-94. PubMed ID: 23076651
[TBL] [Abstract][Full Text] [Related]
2. Tetraidothyroacetic acid (tetrac) and tetrac nanoparticles inhibit growth of human renal cell carcinoma xenografts.
Yalcin M; Bharali DJ; Lansing L; Dyskin E; Mousa SS; Hercbergs A; Davis FB; Davis PJ; Mousa SA
Anticancer Res; 2009 Oct; 29(10):3825-31. PubMed ID: 19846915
[TBL] [Abstract][Full Text] [Related]
3. Description of 2 angiogenic phenotypes in clear cell renal cell carcinoma.
Edeline J; Mottier S; Vigneau C; Jouan F; Perrin C; Zerrouki S; Fergelot P; Patard JJ; Rioux-Leclercq N
Hum Pathol; 2012 Nov; 43(11):1982-90. PubMed ID: 22626276
[TBL] [Abstract][Full Text] [Related]
4. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
[TBL] [Abstract][Full Text] [Related]
5. Combined gene expression profiling and RNAi screening in clear cell renal cell carcinoma identify PLK1 and other therapeutic kinase targets.
Ding Y; Huang D; Zhang Z; Smith J; Petillo D; Looyenga BD; Feenstra K; Mackeigan JP; Furge KA; Teh BT
Cancer Res; 2011 Aug; 71(15):5225-34. PubMed ID: 21642374
[TBL] [Abstract][Full Text] [Related]
6. The CXCL7/CXCR1/2 axis is a key driver in the growth of clear cell renal cell carcinoma.
Grépin R; Guyot M; Giuliano S; Boncompagni M; Ambrosetti D; Chamorey E; Scoazec JY; Negrier S; Simonnet H; Pagès G
Cancer Res; 2014 Feb; 74(3):873-83. PubMed ID: 24335961
[TBL] [Abstract][Full Text] [Related]
7. Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.
Kosari F; Parker AS; Kube DM; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Vasmatzis G
Clin Cancer Res; 2005 Jul; 11(14):5128-39. PubMed ID: 16033827
[TBL] [Abstract][Full Text] [Related]
8. Expression of the PTTG1 oncogene is associated with aggressive clear cell renal cell carcinoma.
Wondergem B; Zhang Z; Huang D; Ong CK; Koeman J; Hof DV; Petillo D; Ooi A; Anema J; Lane B; Kahnoski RJ; Furge KA; Teh BT
Cancer Res; 2012 Sep; 72(17):4361-71. PubMed ID: 22805307
[TBL] [Abstract][Full Text] [Related]
9. Rac Signaling Drives Clear Cell Renal Carcinoma Tumor Growth by Priming the Tumor Microenvironment for an Angiogenic Switch.
Goka ET; Chaturvedi P; Lopez DTM; Lippman ME
Mol Cancer Ther; 2020 Jul; 19(7):1462-1473. PubMed ID: 32371578
[TBL] [Abstract][Full Text] [Related]
10. [Expression of COX-2 and VEGF and their correlation with angiogenesis in human clear cell renal cell carcinoma].
Chang BD; Cao LS; Zhou HL
Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):687-90. PubMed ID: 20021866
[TBL] [Abstract][Full Text] [Related]
11. An alternative in vivo system for testing angiogenic potential of human neuroblastoma cells.
Mangieri D; Nico B; Coluccia AM; Vacca A; Ponzoni M; Ribatti D
Cancer Lett; 2009 May; 277(2):199-204. PubMed ID: 19150583
[TBL] [Abstract][Full Text] [Related]
12. The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma.
García M; Palma MB; Verine J; Miriuka S; Inda AM; Errecalde AL; Desgrandchamps F; Carosella ED; Tronik-Le Roux D
BMC Cancer; 2020 Jul; 20(1):624. PubMed ID: 32620162
[TBL] [Abstract][Full Text] [Related]
13. Serous neoplasms of the pancreas share many, but not all aspects of their microvascular and angiogenic profile with low-grade clear cell renal cell carcinomas.
Liszka Ł; Pająk J; Gołka D
Pathol Res Pract; 2014 Dec; 210(12):901-8. PubMed ID: 25155377
[TBL] [Abstract][Full Text] [Related]
14. The chick embryo chorioallantoic membrane as a model for tumor biology.
Ribatti D
Exp Cell Res; 2014 Nov; 328(2):314-24. PubMed ID: 24972385
[TBL] [Abstract][Full Text] [Related]
15. Variants in angiogenesis-related genes and the risk of clear cell renal cell carcinoma.
Qin C; Chen J; Li J; Ju X; Zhang S; Cao Q; Han Z; Li P; Shao P; Wang M; Zhang Z; Gu M; Zhang W; Yin C
Mutagenesis; 2014 Nov; 29(6):419-25. PubMed ID: 25239121
[TBL] [Abstract][Full Text] [Related]
16. HAVCR/KIM-1 activates the IL-6/STAT-3 pathway in clear cell renal cell carcinoma and determines tumor progression and patient outcome.
Cuadros T; Trilla E; Sarró E; Vilà MR; Vilardell J; de Torres I; Salcedo M; López-Hellin J; Sánchez A; Ramón y Cajal S; Itarte E; Morote J; Meseguer A
Cancer Res; 2014 Mar; 74(5):1416-28. PubMed ID: 24390735
[TBL] [Abstract][Full Text] [Related]
17. Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer.
Mertz KD; Demichelis F; Kim R; Schraml P; Storz M; Diener PA; Moch H; Rubin MA
Hum Pathol; 2007 Oct; 38(10):1454-62. PubMed ID: 17889675
[TBL] [Abstract][Full Text] [Related]
18. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile.
Baldewijns MM; Thijssen VL; Van den Eynden GG; Van Laere SJ; Bluekens AM; Roskams T; van Poppel H; De Bruïne AP; Griffioen AW; Vermeulen PB
Br J Cancer; 2007 Jun; 96(12):1888-95. PubMed ID: 17505508
[TBL] [Abstract][Full Text] [Related]
19. Pericyte coverage of differentiated vessels inside tumor vasculature is an independent unfavorable prognostic factor for patients with clear cell renal cell carcinoma.
Cao Y; Zhang ZL; Zhou M; Elson P; Rini B; Aydin H; Feenstra K; Tan MH; Berghuis B; Tabbey R; Resau JH; Zhou FJ; Teh BT; Qian CN
Cancer; 2013 Jan; 119(2):313-24. PubMed ID: 22811049
[TBL] [Abstract][Full Text] [Related]
20. Identification of angiogenesis-related miRNAs in a population of patients with renal clear cell carcinoma.
Li HC; Li JP; Wang ZM; Fu DL; Li ZL; Zhang D; Gan WM; Chong T
Oncol Rep; 2014 Nov; 32(5):2061-9. PubMed ID: 25119741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
